Orphalan announces NMPA™s approval of its trientine tetrahydrochloride product
18 Jan 2024 //
GLOBENEWSWIRE
Orphalan announces US commercial launch of Cuvrior
20 Apr 2023 //
GLOBENEWSWIRE
Orphalan announces publication of results from the CHELATE trial
29 Sep 2022 //
GLOBENEWSWIRE
Orphalan announces enrolment in International Wilson`s Disease Patient Registry
26 Jul 2022 //
GLOBENEWSWIRE
Orphalan announces data from secondary analyses of the CHELATE trial
22 Jun 2022 //
GLOBENEWSWIRE